Search for: "STATE v. INDIAN ROYALTY CO. INDIAN ROYALTY CO."
Results 61 - 68
of 68
Sorted by Relevance
|
Sort by Date
2 May 2008, 7:00 am
, India: Mint story on patent loophole in India regarding the importation of generics: (Spicy IP), India: WHO lambasts Indian drug regulatory system: (Spicy IP), India: Minister to ensure that reduced excise duty to reflect in drug prices: (Spicy IP), India: SCC journal article ‘Intellectual property rights and the challenges faced by the pharmaceutical industry’: (Spicy IP), Poland: Trade marks for medicines: (Class 46), US: IPO publishes letter… [read post]
19 Sep 2008, 6:00 pm
: (Danny Weitzner - Open Internet Policy), United States: How many lines is de minimis? [read post]
11 Feb 2012, 1:43 am
Lurgi Energie Und Entsorgung GmbH- the matter was dismissed for becoming infructuous on 07.01.2007- see order) 09.03.06: Delhi High Court stayed proceedings befor it.03.04.07: In view of the dismissal of Civil Appeal 339/ 2003, the Supreme Court listed the matter alongwith Civil Appeal 7019/2005-Bharat Aluminium Co. v. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
19 Apr 2022, 5:05 am
United States v. [read post]
28 Apr 2008, 11:00 am
: Art, access and the public domain after Bridgeman v Corel’ – 29 April, New York City: (creativecommons.org), (Public Knowledge) US: ACI ‘Paragraph IV disputes’ conference – 30 April – 1 May, New York City: (Orange Book Blog) Pharma & Biotech Pharma & Biotech - General Canada: Patented Medicine Prices Review Board (PMPRB) departs from its guidelines in determining price in recent decision: (Gowlings), … [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
25 Oct 2008, 12:18 am
(Intellectual Property Marketing Advisor) How reasonable is your royalty? [read post]
